EGF Induces MMP1 in Bladder Tumor Cells and Urine
Author Information
Author(s): JE Nutt, JK Mellon, K Qureshi, J Lunec
Primary Institution: University of Newcastle upon Tyne
Hypothesis
Does epidermal growth factor (EGF) induce matrix metalloproteinase-1 (MMP1) production in human bladder tumor cell lines?
Conclusion
MMP1 levels increase significantly in bladder tumor cell lines after EGF treatment and are detectable in the urine of patients with bladder tumors.
Supporting Evidence
- EGF treatment led to a 20-fold increase in MMP1 mRNA levels in RT112 cells.
- MMP1 protein was detected in urine from patients with bladder tumors.
- Urine MMP1 concentrations increased with tumor stage and grade.
Takeaway
When bladder cancer cells are treated with a substance called EGF, they make more of a protein called MMP1, which can also be found in the urine of patients with bladder cancer.
Methodology
The study involved treating two human bladder tumor cell lines with EGF and measuring MMP1 mRNA and protein levels, as well as analyzing urine samples from patients.
Limitations
The study primarily focused on two cell lines and may not represent all bladder tumors.
Participant Demographics
Patients included 10 with stage T2-T4 tumors, 5 with stage T1, 17 with stage Ta tumors, and 17 clear of tumors.
Statistical Information
P-Value
0.029
Statistical Significance
p=0.003
Want to read the original?
Access the complete publication on the publisher's website